RG1068 (Synthetic Human Secretin)

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Autism

Conditions

Autism

Trial Timeline

Apr 1, 2002 → Jan 1, 2004

NCT ID

NCT00036244

About RG1068 (Synthetic Human Secretin)

RG1068 (Synthetic Human Secretin) is a phase 3 stage product being developed by Repligen for Autism. The current trial status is completed. This product is registered under clinical trial identifier NCT00036244. Target conditions include Autism.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (4)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00660335	Phase 3	Completed	Mar 1, 2008	Oct 1, 2009	Pancreatitis
NCT00216294	Phase 2	Completed	Feb 1, 2005	Apr 1, 2006	Obsessive Compulsive Disorder (OCD)
NCT00036231	Phase 3	Terminated	Apr 1, 2002	—	Autism
NCT00036244	Phase 3	Completed	Apr 1, 2002	Jan 1, 2004	Autism

Competing Products

20 competing products in Autism

See all competitors

Product	Company	Stage	Hype Score
Ketamine + Placebo	Roivant Sciences	Phase 1	30
Cord Tissue Mesenchymal Stromal Cells	Cryo-Cell	Phase 2	44
Suramin Sodium	PaxMedica	Phase 2	44
NORSPAN Buprenorphine Transdermal Patchs for Very-low dose group + NORSPAN Buprenorphine Transdermal Patchs for Lower dose group + NORSPAN Buprenorphine Transdermal Patchs for higher dose group	Shionogi	Pre-clinical	23
Lurasidone 20 mg daily + Lurasidone + Placebo	Sumitomo Pharma	Phase 3	77
Cariprazine + Placebo	AbbVie	Phase 3	77
Cariprazine	AbbVie	Phase 1	33
Omalizumab Injection [Xolair]	Novartis	Phase 1	33
RO7017773	Roche	Phase 1	33
Placebo + RO7017773	Roche	Phase 2	52
Balovaptan	Roche	Phase 1	33
Balovaptan	Roche	Phase 1	33
Balovaptan + Esomeprazole	Roche	Phase 1	33
Placebo + RG7314	Roche	Phase 2	52
Placebo + RO5285119	Roche	Phase 2	52
Balovaptan + Placebo	Roche	Phase 3	77
KarXT + KarX-EC + KarXT + KarX-EC Matching Placebo	Bristol Myers Squibb	Phase 3	76
Aripiprazole	Bristol Myers Squibb	Phase 2	51
KarXT + KarX-EC + KarXT + KarX-EC Matching Placebo	Bristol Myers Squibb	Phase 3	76
Brexpiprazole + Placebo	Lundbeck	Phase 3	74

Other Products from Repligen

RG1068 (Synthetic Human Secretin)Phase 3

RG1068 (synthetic human secretin)Phase 3

UridinePhase 2

RG1068 (Synthetic Human Secretin)Phase 2

RG2417 + PlaceboPhase 2